Home
Site Map
Investors
Press Releases
Contact Us
Clinical Trials
Phase III — Hepatocellular Carcinoma (HCC)
Phase III — Metastatic Colorectal Cancer (MCRC)
Phase I — Benign Prostatic Hyperplasia (BPH)
Pipeline
Hepatocellular Carcinoma (HCC)
Metastatic Colorectal Cancer (MCRC)
Glioma
Benign Prostatic Hyperplasia (BPH)
Litx™ Therapy
Litx™ Advantages
Publications
The Company
Executive Team
Board of Directors
Scientific Advisory Board
Careers
Contact LSO
Investors
Press Releases
Contact Us
Press Releases
View Archive: 2008 |
2007
|
2006
|
2005
July 15, 2008 –
Light Sciences Oncology Raises $40.1 Million in Series C Financing
July 7, 2008 –
Light Sciences Oncology Begins Clinical Trials of Litx Therapy in Patients with Enlarged Prostate
April 7, 2008 –
Light Sciences Oncology Appoints David P. Holveck to Its Board of Directors
